Home LiteratureArticle Details
PMID: 25301738 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Regulation of the viability of Nf1 deficient cells by PKC isoforms.

Oncotarget ·Vol. 5 ·No. 21 ·2014-11-15 ·页码 10709-17

Zhou X, Shen L, Parris T, Huang J, Yi B, Helou K, Chen C

Abstract

Suppression of protein kinase C (PKC) is known to be synthetically lethal with ras mutations in various types of cancer cells. The studies also showed that blockade of PKC affected the viability of Nf1 deficient cells. Since PKC family consists of more than 10 isoforms, our study aimed at identifying which isoform(s) played the crucial role in sensitizing Nf1 deficient cells to apoptosis. Using genetic and chemical PKC inhibitors, we demonstrated that the concurrent inhibition of PKC α and β induced Nf1 deficient ST or 96.2 cells, but not SNF02.2 cells with a normal Nf1 or ST cells ectopically expressing Nf1 effective domain gene, to apoptosis. In this process, PKC δ in Nf1 deficient cells, but not in ST/Nf1 cells, was upregulated and translocated to the nucleus. Furthermore, caspase 3 was cleaved and cytochrome c was released to the cytosol. Thus, it appeared that PKC δ and α/β are the crucial components for sustaining the aberrant Ras signaling and further viability of Nf1 deficient cells. The abrogation of these two isoforms activated their opponent PKC δ for switching on the caspase 3-governed apoptotic machinery.

MeSH 主题词
Apoptosis Blotting, Western Caspases/metabolism Cell Cycle Cell Proliferation Cells, Cultured Cytochromes c/metabolism Humans Neurofibromin 1/deficiency,genetics Protein Kinase C beta/antagonists & inhibitors,genetics,metabolism Protein Kinase C-alpha/antagonists & inhibitors,genetics,metabolism Protein Kinase C-delta/antagonists & inhibitors,genetics,metabolism Protein Kinase Inhibitors/pharmacology RNA, Messenger/genetics Real-Time Polymerase Chain Reaction Reverse Transcriptase Polymerase Chain Reaction Signal Transduction ras Proteins/metabolism
化学物质
Neurofibromin 1 Protein Kinase Inhibitors RNA, Messenger Cytochromes c Protein Kinase C beta Protein Kinase C-alpha Protein Kinase C-delta Caspases ras Proteins
作者与单位
共 7 位作者,点击展开单位 / ORCID
Zhou Xiaodong
Center for Drug Discovery, Northeastern University, Boston, USA. The First Affiliated Hospital of Nanchang University, Nanchang, China.
Shen Ling
Center for Drug Discovery, Northeastern University, Boston, USA.
Parris Toshima
The Institute of Clinical Sciences, Gothenburg University, Gothenburg, SE.
Huang Junchi
Center for Drug Discovery, Northeastern University, Boston, USA.
Yi Bo
Center for Drug Discovery, Northeastern University, Boston, USA. The Jiangxi Province Tumor Hospital, Nanchang, China.
Helou Khalil
The Institute of Clinical Sciences, Gothenburg University, Gothenburg, SE.
Chen Changyan
Center for Drug Discovery, Northeastern University, Boston, USA. The Institute of Clinical Sciences, Gothenburg University, Gothenburg, SE.
Article Info
Journal
Oncotarget
Abbr.
Oncotarget
ISSN
1949-2553
Published
2014-11-15
页码
10709-17
Language
English
Country/Region
United States
NLM ID
101532965
基金资助
NCI NIH HHS · R01 CA153354 · United States
NCI NIH HHS · NIH R01CA153354 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com